Diane A.J. van der Biessen

Phase I Study of BI 853520, an Inhibitor of Focal Adhesion Kinase, in Patients with Advanced or Metastatic Nonhematologic Malignancies

Maja J.A. de Jonge, Neeltje Steeghs, Martijn P. Lolkema et al. · Targeted Oncology · 2019 · 72 citations · Full text

Phase I Study of RGB-286638, A Novel, Multitargeted Cyclin-Dependent Kinase Inhibitor in Patients with Solid Tumors

Diane A.J. van der Biessen, Herman Burger, Peter de Bruijn et al. · Clinical Cancer Research · 2014 · 30 citations · Full text

Understanding how coping strategies and quality of life maintain hope in patients deliberating phase I trial participation

Diane A.J. van der Biessen, Peer G. van der Helm, Dennis Klein et al. · Psycho-Oncology · 2017 · 27 citations

Evaluation of Patient Enrollment in Oncology Phase I Clinical Trials

Diane A.J. van der Biessen, Merlijn A. Cranendonk, Gaia Schiavon et al. · The Oncologist · 2013 · 18 citations · Full text

Phase I study of intermittent olaparib capsule or tablet dosing in combination with carboplatin and paclitaxel (part 2)

Ruud van der Noll, Agnes Jager, Joo Ern Ang et al. · Investigational New Drugs · 2019 · 18 citations · Full text

Oncology, Part 2, Pharmacology +8